Coagulation state of critically ill patients with acute renal failure undergoing continuous veno-venous citrate-dialysis

• Conditions: Coagulation state in patients with acute renal failure undergoing citratedialysis; D68.9; Coagulation defect, unspecified

• Registration Number: DRKS00004336
• Lead Sponsor: AKH Wien

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-08-29
• Study Completion: 2018-11-21
• Results First Posted: 2021-06-14
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

Acute renal failure indicating CRRT
and VTE prophylaxis with enoxaparin 40mg/d s.c.

Exclusion Criteria

1.Age < 18 years
2.Contraindication for thromboembolic prophylaxis with heparins

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
to find out about correlation between ROTEM® / TG / Multiplate and defined clinical endpoints (venous thromboembolism, mortality)<br>ROTEM and TG will be done twice a day for 3 days

Secondary Outcome Measures

Name	Time	Method
observation of the time course of anti Xa, ROTEM®, TG and Multiplate in critically ill patients receiving standard pharmacological prophylaxis and undergoing citrate-dialysis <br>ROTEM and TG will be done twice a day and antiXa four times a day over a period of three days